Amelia Wong is a RECATOOLS editorial persona focused on consumer technology, digital wellness, health-related tools, calculators, and practical lifestyle explainers. Articles under this byline help readers understand everyday data, online tools, and wellness-related information without replacing professional advice.

About this byline

Amelia Wong is a RECATOOLS editorial persona for consumer technology and wellness-related tool coverage. Articles are produced and reviewed under RECATOOLS editorial supervision.

Editorial responsibility for this byline rests with Jeffrey Tan (Tan Seng Fei), RECASYS, Singapore. Our Editorial Policy sets out how sources are reviewed, how AI-assisted workflows are used, and how editorial desks and personas are defined.

189
Articles
Health & Wellness
Primary beat
Jun 2026
Writing since
~1269 min
Total reading
All 189 Health & Wellness 90 Consumer Tech 55 Home & Living 30 Personality 9 Chinese Culture 4 AI & ML 1

Articles · Health & Wellness Showing 21–30 of 90

A researcher in a face mask and safety glasses looking through a microscope
Health & Wellness

Infections Caused 2.3 Million Cancers in 2024, and a Larger Share in Southeast Asia

An IARC analysis in The Lancet Oncology attributes one in eight new tumours worldwide to infectious agents. In the region, Epstein-Barr virus drives nasopharyngeal cancer.

1 Oct 2026 · 4 min read
Bins of brightly coloured gummy sweets with serving tongs
Health & Wellness

Transplant Patients Who Ate More Sweets on Antibiotics Lost More Gut Bacteria

A Nature study of 9,419 hospital meals linked sugar during antibiotic treatment to bigger blooms of Enterococcus. Mouse tests agreed; the authors say trials are needed before advice changes.

1 Oct 2026 · 4 min read
A needle-free oral dosing syringe of the kind used to give liquid medicine
Health & Wellness

The First Approved Drug for MCT8 Deficiency Treats the Body's Excess Hormone, Not the Brain

The FDA approved Egetis's Emcitate (tiratricol) on 28 September. It lowers the thyroid hormone that builds up in the blood; the label makes no claim on the disease's neurological effects.

30 Sep 2026 · 4 min read
A microscope objective above a glass slide holding a small green specimen
Health & Wellness

A Drug Aimed at a Weak Point in Some Cancers Shrank Tumours in 7 of 66 Patients

The first WRN inhibitor tested in people was tolerable and controlled disease in 74% of patients whose MSI cancers had mostly already been treated with immunotherapy.

30 Sep 2026 · 4 min read
An open hand holding a small pile of tablets
Health & Wellness

A Chinese GLP-1 Pill Taken Without Fasting Cut Blood Sugar in a Phase 3 Trial

Hengrui's safiglipron lowered HbA1c by up to 1.45 points against placebo in 284 people with early type 2 diabetes. The results are in Nature Medicine.

30 Sep 2026 · 4 min read
Tablets of different colours in blister packs
Health & Wellness

Tavapadon, a Parkinson's Drug Aimed at Different Dopamine Receptors, Wins FDA Approval

AbbVie's Juvmo, tavapadon, is the first to target D1 and D5 receptors. It beat placebo in three trials but was never tested against existing drugs.

29 Sep 2026 · 3 min read
A person holding an insulin injection pen
Health & Wellness

The FDA Approved a Once-a-Week Insulin for Type 2 Diabetes

Lilly's Onswik lowered blood sugar about as well as daily insulin in four trials. It is not recommended for type 1 diabetes.

28 Sep 2026 · 4 min read
A chest X-ray showing the ribcage and spine
Health & Wellness

The FDA Approved a Third Drug for a Disease That Turns Muscle Into Bone

Atebrioz joins two earlier treatments for fibrodysplasia ossificans progressiva, one approved five weeks ago. The approval rests on 24 weeks of CT scans in 63 patients.

27 Sep 2026 · 4 min read
A coal-fired power station with a chimney and cooling tower in hazy air
Health & Wellness

Power-Plant Pollution Deaths in Indian Cities Rose Twentyfold Since 2000, Study Estimates

A Nature Cities study puts the toll near 300,000 in 2020, up from about 15,000. The same growth cut smoke deaths inside homes as clean cooking spread.

27 Sep 2026 · 4 min read
Softgel capsules in a blister pack
Health & Wellness

A Korean Group's US Subsidiary Wins FDA Approval for a Bile-Duct Cancer Drug

Lyrfigtu shrank tumours in 46 per cent of patients in a trial with no comparison group. HLB calls it a first for a Korean company filing directly; the drug came from an American developer.

27 Sep 2026 · 5 min read
Editorial Policy →
Advertisement